The FDA on May 11 approved Eli Lilly and partner Incyte’s baricitinib, which goes by the brand name Olumiant, to treat COVID-19 in certain hospitalized adults.
Read the full post on Becker's Hospital Review - Healthcare News
FDA approves new indication for drug to treat severe COVID-19
